Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 75, Pages (October 2017)

Similar presentations


Presentation on theme: "Volume 75, Pages (October 2017)"— Presentation transcript:

1 Volume 75, Pages 73-79 (October 2017)
Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus  Renée A. Shellhaas, Anne T. Berg, Zachary M. Grinspan, Courtney J. Wusthoff, John J. Millichap, Tobias Loddenkemper, Jason Coryell, Russell P. Saneto, Catherine J. Chu, Sucheta M. Joshi, Joseph E. Sullivan, Kelly G. Knupp, Eric H. Kossoff, Cynthia Keator, Elaine C. Wirrell, John R. Mytinger, Ignacio Valencia, Shavonne Massey, William D. Gaillard  Pediatric Neurology  Volume 75, Pages (October 2017) DOI: /j.pediatrneurol Copyright © 2017 Elsevier Inc. Terms and Conditions

2 FIGURE 1 First and second medication choices for 495 children with early-life epilepsy. Pediatric Neurology  , 73-79DOI: ( /j.pediatrneurol ) Copyright © 2017 Elsevier Inc. Terms and Conditions

3 FIGURE 2 Distribution of first anti-seizure medication selected in nine pediatric epilepsy centers. Among the nine study centers that enrolled at least 20 children with nonsyndromic epilepsy, levetiracetam was the most commonly selected first medication at each hospital; however, the proportion of children prescribed levetiracetam at the sites ranged from 29% to 75% (P < 0.0001). TPM, topiramate; OXC, oxcarbazepine; PB, phenobarbital; LVT, levetiracetam. Pediatric Neurology  , 73-79DOI: ( /j.pediatrneurol ) Copyright © 2017 Elsevier Inc. Terms and Conditions

4 FIGURE 3 Second anti-seizure medication selected for 233 children with early-life epilepsy. For 233 children a second anti-seizure medication was prescribed because of lack of seizure control (n = 188) or side effects (n = 29). Among 109 children who received a drug other than levetiracetam as their initial medication, 68 (62%) received levetiracetam as their second medication. LTG, lamotrigine; CLB, clobazam; ZNM, zonisamide; TPM, topiramate; OXC, oxcarbazepine; PB, phenobarbital; LVT, levetiracetam. Pediatric Neurology  , 73-79DOI: ( /j.pediatrneurol ) Copyright © 2017 Elsevier Inc. Terms and Conditions


Download ppt "Volume 75, Pages (October 2017)"

Similar presentations


Ads by Google